Burning Rock Biotech Limited BNR
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.93% | 80.79% | 53.11% | 91.01% | 89.04% |
| Total Depreciation and Amortization | -- | -57.30% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -82.92% | -- | -- | -- |
| Total Other Non-Cash Items | -23.93% | -8.87% | 506.49% | -151.63% | -112.17% |
| Change in Net Operating Assets | -- | -64.96% | -- | -- | -- |
| Cash from Operations | -30.81% | 22.65% | 154.16% | -8.76% | 42.25% |
| Capital Expenditure | -- | 1.71% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -44.39% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.01% | 35.80% | -178.32% | 191.37% | 36.65% |
| Cash from Investing | 75.01% | 60.05% | -178.32% | 191.37% | 36.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -99,900.00% | -- | -- | -- |
| Cash from Financing | -- | -36.89% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -1,035.90% | -250.48% | 52.16% | -116.74% | 460.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.28% | -40.13% | 134.36% | -7.11% | 42.56% |